Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Investing.com -- Tempus AI, Inc. (NASDAQ:TEM) stock rose 5% on Monday after the company announced it received 510 (k) clearance from the U.S. Food and Drug Administration for its RNA-based Tempus xR ...

Tempus AI Inc. shares rose after it said it received 510 (k) clearance from the Food and Drug Administration for its RNA-based in vitro diagnostic device. Its stock recently rose 5.2% to $92.85 in ...

Through a comprehensive approach combining transcriptomic profiling, histological analysis, and functional validation in ...

Alcohol doesn’t just damage the liver — it locks its cells in a strange “in-between” state that prevents them from healing.

Tempus AI stock surged to a record high Monday, and then dipped, after the FDA cleared its new device to help drugmakers ...

Gastric cancer often develops through a gradual sequence of changes, beginning with superficial gastritis and advancing ...

Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced it will showcase its leadership in pediatric neurology through three poster presentations and a ...

Lab-grown brain cells improved stroke recovery in mice by repairing circuits and reducing damage. Human trials could follow within 5–7 years.

Ants rely on pheromones to coordinate their societies, but how do their neurons avoid sensory confusion? Researchers studying ...

Autism-linked genes evolved rapidly in humans. They may have aided brain growth and language. A recent study published in Molecular Biology and Evolution by Oxford University Press suggests that the r ...